These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35821167)

  • 21. The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review.
    Vermaak E; Tansley SL; McHugh NJ
    Clin Rheumatol; 2015 Dec; 34(12):2089-95. PubMed ID: 26299472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal lactate levels in patients with polymyositis and dermatomyositis: the benefits of a specific rehabilitative program.
    Bertolucci F; Neri R; Dalise S; Venturi M; Rossi B; Chisari C
    Eur J Phys Rehabil Med; 2014 Apr; 50(2):161-9. PubMed ID: 23820876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistive exercise in the rehabilitation of polymyositis/dermatomyositis.
    Escalante A; Miller L; Beardmore TD
    J Rheumatol; 1993 Aug; 20(8):1340-4. PubMed ID: 8230016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intravenous immunoglobulins in polymyositis and dermatomyositis].
    Chérin P; Herson S
    Rev Med Interne; 1999; 20 Suppl 4():436s-439s. PubMed ID: 10522319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis: a systematic review.
    Ge Y; Zhou H; Shi J; Ye B; Peng Q; Lu X; Wang G
    Clin Rheumatol; 2015 Dec; 34(12):2097-103. PubMed ID: 26328518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis.
    Dalakas MC
    Neurology; 1998 Dec; 51(6 Suppl 5):S37-45. PubMed ID: 9851729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 2020.
    Sun KY; Fan Y; Wang YX; Zhong YJ; Wang GF
    Semin Arthritis Rheum; 2021 Feb; 51(1):175-191. PubMed ID: 33383294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of inflammatory myopathies.
    Pipitone N; Salvarani C
    Expert Rev Clin Immunol; 2018 Jul; 14(7):607-621. PubMed ID: 29952659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Exercise Interventions and Outcomes After Hip Arthroplasty: A Systematic Review and Meta-analysis.
    Saueressig T; Owen PJ; Zebisch J; Herbst M; Belavy DL
    JAMA Netw Open; 2021 Feb; 4(2):e210254. PubMed ID: 33635329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003643. PubMed ID: 16034905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB; Gordon P
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003643. PubMed ID: 19821312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Juvenile dermatomyositis and polymyositis: a follow-up study of long-term sequelae.
    Collison CH; Sinal SH; Jorizzo JL; Walker FO; Monu JU; Snyder J
    South Med J; 1998 Jan; 91(1):17-22. PubMed ID: 9438396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life correlates with muscle strength in patients with dermato- or polymyositis.
    Poulsen KB; Alexanderson H; Dalgård C; Jacobsen S; Weile L; Diederichsen LP
    Clin Rheumatol; 2017 Oct; 36(10):2289-2295. PubMed ID: 28585061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscle Strength and Muscle Endurance During the First Year of Treatment of Polymyositis and Dermatomyositis: A Prospective Study.
    Alexanderson H; Regardt M; Ottosson C; Alemo Munters L; Dastmalchi M; Dani L; Lundberg IE
    J Rheumatol; 2018 Apr; 45(4):538-546. PubMed ID: 29419464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis.
    Alexanderson H; Dastmalchi M; Esbjörnsson-Liljedahl M; Opava CH; Lundberg IE
    Arthritis Rheum; 2007 Jun; 57(5):768-77. PubMed ID: 17530676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic efficacy and safety of JAK inhibitors in treating polymyositis/dermatomyositis: a single-arm systemic meta-analysis.
    Ma C; Liu M; Cheng Y; Wang X; Zhao Y; Wang K; Wang W
    Front Immunol; 2024; 15():1382728. PubMed ID: 38576610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of aquatic high-intensity interval training on aerobic performance, strength and body composition in a non-athletic population: systematic review and meta-analysis.
    Depiazzi JE; Forbes RA; Gibson N; Smith NL; Wilson AC; Boyd RN; Hill K
    Clin Rehabil; 2019 Feb; 33(2):157-170. PubMed ID: 30064253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis.
    Wang D; Zhang H; Cao M; Tang Y; Liang J; Feng X; Wang H; Hua B; Liu B; Sun L
    Ann Rheum Dis; 2011 Jul; 70(7):1285-8. PubMed ID: 21622775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise as an adjuvant treatment in persistent active polymyositis.
    Mattar MA; Gualano B; Roschel H; Perandini LA; Dassouki T; Lima FR; Shinjo SK; de Sá Pinto AL
    J Clin Rheumatol; 2014 Jan; 20(1):11-5. PubMed ID: 24356483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Exercise Intervention on Peripheral Skeletal Muscle in Stable Patients With COPD: A Systematic Review and Meta-Analysis.
    Li P; Li J; Wang Y; Xia J; Liu X
    Front Med (Lausanne); 2021; 8():766841. PubMed ID: 34869477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.